Skip to main content
. 2021 Dec 27;14(1):115. doi: 10.3390/cancers14010115
DFS disease-free survival
DSS disease-specific survival
EC endometrial cancer
FIGO The International Federation of Gynecology and Obstetrics
CHRT chemoradiotherapy
CHT chemotherapy
LVSI lymphovascular space invasion
NEC non-endometrioid carcinoma
OS overall survival
RT radiotherapy
HR hazard ratio
CI confidence interval